Piramal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sales

4,390.11

3,443.22

3,094.95

2,938.81

Operating profit

617.92

97.53

397.30

618.93

Interest

107.10

115.87

53.55

4.71

Gross profit

712.88

322.73

567.34

812.19

EPS (Rs)

2.96

0.58

2.89

5.75

Other income

202.06

341.07

223.59

197.97

Stock adjustment

-61.62

53.31

-30.17

57.86

Raw material

1,545.55

1,166.48

1,003.68

986.70

Power and fuel

-

-

-

-

Employee expenses

613.93

548.50

425.30

395.15

Excise

-

-

-

-

Admin and selling expenses

-

-

-

-

Research and development expenses

-

-

-

-

Expenses capitalised

-

-

-

-

Other expenses

1,674.33

1,577.40

1,298.84

880.17

Provisions made

-

-

-

-

Depreciation

205.26

192.08

130.64

143.64

Taxation

116.40

54.19

81.18

115.28

Net profit / loss

391.22

69.50

343.05

571.50

Extra ordinary item

-

-6.96

-12.47

18.23

Prior year adjustments

-

-

-

-

Equity capital

1,322.95

1,193.32

1,185.91

994.60

Equity dividend rate

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

OPM (%)

14.08

2.83

12.84

21.06

GPM (%)

15.52

8.53

17.10

25.89

NPM (%)

8.52

1.84

10.34

18.22